Early research (Phase 1)Study completedNCT06126575
What this trial is testing
A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function
Who this might be right for
Hepatic Impairment
Stemline Therapeutics, Inc. 16